Goldman Sachs’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Goldman Sachs's ACLS Position: Q1 2026 in Review
Goldman Sachs reduced its Axcelis (ACLS) stake by 21% in Q1 2026, selling an estimated $11.7M and leaving 497,624 shares worth $46.3M. The position accounts for 0.01% of the portfolio, ranked #1639.
Goldman Sachs first reported a position in ACLS in Q2 2013 and has held it in 52 quarters since. The position peaked at $99.9M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Goldman Sachs held 497,624 shares of Axcelis worth $46.3M as of Q1 2026.
- Goldman Sachs sold 132,190 Axcelis shares in Q1 2026, an estimated $11.7M.
- Axcelis made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1639 holding.
- Goldman Sachs first reported a position in Axcelis in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Axcelis position peaked at $99.9M in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.